Kyoko Imanaka-Yoshida Selected Research

gellan sulfate

4/2016	Aneurysm Organization Effects of Gellan Sulfate Core Platinum Coil with Tenascin-C in a Simulated Clinical Setting and the Possible Mechanism.
10/2014	Gellan sulfate core platinum coil with tenascin-C promotes intra-aneurysmal organization in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyoko Imanaka-Yoshida Research Topics

Disease

21	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022 - 05/2008
19	Inflammation (Inflammations) 06/2021 - 09/2002
16	Myocarditis (Carditis) 01/2022 - 07/2002
12	Intracranial Vasospasm 01/2020 - 03/2010
11	Fibrosis (Cirrhosis) 02/2022 - 06/2004
11	Myocardial Infarction 01/2021 - 09/2003
10	Heart Failure 01/2021 - 09/2003
10	Neoplasms (Cancer) 10/2020 - 07/2002
9	Brain Injuries (Brain Injury) 01/2022 - 04/2014
6	Heart Diseases (Heart Disease) 05/2021 - 07/2009
6	Aneurysm (Aneurysms) 04/2016 - 01/2003
6	Hyperplasia 02/2015 - 09/2004
6	Neointima 10/2011 - 01/2003
5	Breast Neoplasms (Breast Cancer) 10/2020 - 05/2003
5	Brain Edema (Cerebral Edema) 01/2020 - 01/2016
4	Cardiomyopathies (Cardiomyopathy) 05/2021 - 07/2009
4	Ischemia 01/2015 - 07/2010
4	Ventricular Remodeling 01/2015 - 06/2006
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 06/2006
4	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 08/2012 - 03/2007
4	Thrombosis (Thrombus) 11/2008 - 01/2003
3	Amyloidosis 01/2022 - 01/2014
3	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 06/2021 - 10/2016
3	Vascular Diseases (Vascular Disease) 06/2018 - 10/2007
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015 - 07/2010
3	Pulmonary Hypertension 01/2015 - 10/2007
3	Body Weight (Weight, Body) 01/2015 - 04/2012
3	Aortic Aneurysm (Aneurysm, Aortic) 11/2008 - 08/2005
2	Necrosis 01/2022 - 11/2018
2	Hypertrophy 01/2021 - 09/2013
2	Cicatrix (Scar) 10/2020 - 07/2009
2	Asthma (Bronchial Asthma) 10/2020 - 12/2006
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2020 - 10/2005
2	Neuroinflammatory Diseases 01/2020 - 11/2018
2	Herpes Zoster 01/2017 - 06/2016
2	Aortic Dissection 07/2015 - 10/2013
2	Pathologic Constriction (Stenosis) 06/2007 - 01/2003
1	COVID-19 02/2022
1	Death (Near-Death Experience) 01/2022

Drug/Important Bio-Agent (IBA)

66	TenascinIBA 06/2021 - 07/2002
17	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2012
10	Glycoproteins (Glycoprotein)IBA 06/2021 - 09/2002
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
5	CytokinesIBA 01/2021 - 08/2012
5	Extracellular Matrix ProteinsIBA 01/2019 - 07/2002
5	Matrix Metalloproteinases (MMPs)IBA 06/2016 - 05/2003
4	Toll-Like Receptor 4IBA 01/2020 - 09/2007
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017 - 05/2003
4	Transforming Growth Factor beta (TGF-beta)IBA 04/2016 - 05/2003
4	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 04/2012
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2014 - 05/2007
4	Monoclonal AntibodiesIBA 07/2008 - 09/2002
3	Messenger RNA (mRNA)IBA 02/2022 - 12/2004
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2014
3	IntegrinsIBA 10/2020 - 01/2015
3	Mitogen-Activated Protein KinasesIBA 01/2020 - 04/2012
3	Cilostazol (Pletal)FDA LinkGeneric 01/2020 - 09/2004
3	CollagenIBA 01/2018 - 01/2003
3	Phosphotransferases (Kinase)IBA 01/2017 - 04/2012
3	PlatinumIBA 04/2016 - 10/2005
3	DNA (Deoxyribonucleic Acid)IBA 08/2012 - 09/2007
2	Prealbumin (Transthyretin)IBA 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2020
2	Intravenous Immunoglobulins (IVIG)FDA Link 06/2021 - 10/2016
2	SteroidsIBA 06/2021 - 05/2017
2	Cardiac MyosinsIBA 01/2021 - 11/2014
2	GadoliniumIBA 10/2020 - 01/2018
2	Fibrinogen (Factor I)FDA Link 01/2020 - 06/2003
2	NF-kappa B (NF-kB)IBA 01/2020 - 10/2007
2	Methionine (L-Methionine)FDA Link 11/2019 - 03/2013
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2018 - 01/2015
2	gellan sulfateIBA 04/2016 - 10/2014
2	Phenobarbital (Luminal)FDA Link 04/2016 - 01/2003
2	OsteopontinIBA 01/2016 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 10/2015 - 01/2015
2	InterleukinsIBA 11/2014 - 09/2007
2	Angiotensin IIIBA 09/2013 - 05/2007
2	Atrial Natriuretic Factor (ANF)IBA 09/2013 - 07/2008
2	Tyrosine (L-Tyrosine)FDA Link 01/2013 - 04/2012
2	Platelet-Derived Growth FactorIBA 01/2013 - 04/2012
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2010 - 12/2004
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2010 - 12/2004
2	Immunoglobulin Fab FragmentsIBA 07/2008 - 09/2002
2	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 10/2007 - 09/2004
2	Adenosine Monophosphate (AMP)IBA 10/2007 - 09/2004
2	Poloxamer (Poloxamer 407)IBA 10/2007 - 09/2004
2	Myosins (Myosin)IBA 09/2007 - 07/2002
2	GelatinIBA 03/2005 - 05/2003
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2004 - 09/2003
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2004 - 05/2003
2	Angiotensin Receptor AntagonistsIBA 12/2004 - 06/2004
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2022
1	PropionatesIBA 01/2022
1	TroponinIBA 01/2022

Therapy/Procedure

9	Therapeutics 06/2021 - 04/2010
4	Stents 02/2015 - 01/2003
3	Endovascular Aneurysm Repair 11/2008 - 08/2005
2	Ligation 01/2021 - 08/2005
2	Cell Transplantation 07/2006 - 08/2005
1	Heart-Assist Devices 01/2022